Networks

NIAID participates in or funds many different consortia, clinical trial programs, networks, and research collaborations that help to move science forward. These are listed here, with new ones added all the time. Use the Search for Networks field to narrow your search.

Showing results filtered by:
CLEAR ALL
DMID (Division of Microbiology and Infectious Diseases)
16 Results

Antibacterial Resistance Leadership Group (ARLG)

In 2013, NIAID launched the Antibacterial Resistance Leadership Group (ARLG), a major clinical effort to address antibacterial resistance (AR).

Biocontainment Research Facilities

The National Biocontainment Laboratories (NBLs) and Regional Biocontainment Laboratories (RBLs) provide BSL4/3/2 and BSL3/2 biocontainment facilities, respectively, for research on biodefense and emerging infectious disease agents.

Bioinformatics Resource Centers

The Bioinformatics Resource Centers (BRCs) for Infectious Diseases program was initiated in 2004 with the main objective of providing public access to computational platforms and analysis tools that enable  collecting, archiving, updating, and integrating a variety of genomics and related research data relevant to infectious diseases, and pathogens and their interaction with hosts

Centers of Excellence for Influenza Research and Surveillance (CEIRS)

The National Institute of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Surveillance (CEIRS) program is an integrated network of centers designed to bring together multidisciplinary teams of researchers that perform surveillance related research integrated with research on host immune response, viral pathogenesis, and the factors that control the emerg

Centers of Excellence for Translational Research (CETR)

In 2014, NIAID established the Centers of Excellence for Translational Research (CETR) program. Supported translational activities will range from very early discovery-based efforts to late-stage preclinical development.

Collaborative Influenza Vaccine Innovation Centers (CIVICs)

CIVICs is a network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines. The CIVICs program will include three Vaccine Centers, one Vaccine Manufacturing and Toxicology Core, two Clinical Cores, and one Statistical, Data Management, and Coordination Center (SDMCC). 

Functional Genomics Program

The Functional Genomics Program for understanding the functions of uncharacterized genes in infectious disease pathogens aims to generate experimental data to determine the biochemical function(s) of hypothetical genes, unknown open reading frames, and noncoding RNAs.

Genomic Centers for Infectious Diseases (GCID)

The NIAID Genomic Centers for Infectious Diseases (GCID) provide insights into the biology of microbes, their role in pathogenesis, and their interactions with the host, including the microbiome, by supporting a diverse set of genomic capabilities, such as next-generation sequencing and related genomic technologies.

Immune Mechanisms of Protection Against Mycobacterium tuberculosis Centers (IMPAc-TB)

The Immune Mechanisms of Protection Against Mycobacterium tuberculosis Centers (IMPAc-TB) program is an initiative established by NIAID in 2019 to elucidate the immune responses needed to protect against infection with Mycobacterium tuberculosis (Mtb).

Infectious Diseases Clinical Research Consortium

In 2019, NIAID established the Infectious Diseases Clinical Research Consortium, a clinical trials network that encompasses the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs) and a new consortium leadership group.

International Centers of Excellence for Malaria Research (ICEMR)

 The ICEMRS are a global network of independent research centers in malaria-endemic settings, established by NIAID to provide the knowledge, tools, and evidence-based strategies crucial to understanding, controlling, and, ultimately, preventing malaria.

Structural Genomics Centers for Infectious Diseases

The Structural Genomics Centers for Infectious Diseases (SGCID) apply state-of-the-art high-throughput technologies and methodologies to experimentally characterize the three dimensional (3-D) atomic structure of proteins or other molecules that play an important biological role in human pathogens and infectious diseases.

Systems Biology Consortium for Infectious Diseases

The NIAID/Division of Microbiology and Infectious Diseases (DMID) Systems Biology Consortium for Infectious Diseases is a group of interdisciplinary scientists that bridge disparate scientific disciplines including microbiology, immunology, infectious diseases, microbiome, mathematics, physics, bioinformatics, computational biology, machine learning, statistical methods, and mathematical modeli

Trans-NIH Microbiome Working Group (TMWG)

The Trans-NIH Microbiome Working Group (TMWG) was established in 2012 by Dr. Lita Proctor (NHGRI) to provide a forum for coordinating NIH extramural research activities related to the human microbiome. TMWG membership is open to all extramural program staff from ICs with an interest in the human microbiome. The TMWG meets monthly.

Tropical Medicine Research Centers (TMRCs)

NIAID awarded the Tropical Medicine Research Centers (TMRCs) in 1991 to establish international research sites in disease-endemic countries. The program was renewed in 2017, with the funding of seven Centers (five new Centers and two renewals).

Tuberculosis Research Units Network (TBRU-N)

First established in 1994, the Tuberculosis Research Units Network (TBRU-N) integrates scientific and clinical research disciplines to study aspects of human TB in endemic countries. The Network is comprised of four multi-project awards to study TB latency and persistence and their relation to active TB disease in humans.